Bionano to Report Third Quarter 2026 Financial Results and Host a Conference Call Webcast on November 10, 2026
Bionano Laboratories Announces Expansion of Diagnostic Testing Based on Optical Genome Mapping for Hematologic Malignancies
Bionano Genomics Stock Surges Tuesday: What's Going On?
Bionano Announces Three New Peer-Reviewed Studies Demonstrate Clinical Value of Bionano's Optical Genome Mapping Across Myelodysplastic Syndromes and Acute Myeloid Leukemia
Bionano Genomics Highlights Three New Independently Authored, Peer-Reviewed Publications Showing Clinical Utility Of OGM In High-Risk Hematologic Malignancies
Bionano Laboratories Announces Proposed Local Coverage Determination (LCD) from MolDX for Genome-Wide Detection of Structural Variants in Hematologic Neoplasms
Bionano Genomics Subsidiary Says MolDX Issues Proposed LCD For Genome-Wide Molecular Methodologies For Detection Of Copy Number Alterations And Structural Variants In Hematologic Neoplasms
Bionano Laboratories Announces New York State Department of Health Approval of Lab Developed Tests Based on Optical Genome Mapping
Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Bionano Genomics (BNGO) Q2 2026 Earnings Call Transcript
Bionano Genomics, Inc. 2026 Q2 - Results - Earnings Call Presentation
Bionano Genomics Inc (BNGO) (Q2 2026) Earnings Call Highlights: Record Flow Cell Sales and ...
Bionano Genomics, Inc. Q2 2026 Earnings Call Summary
Bionano Reports Second Quarter 2026 Results and Provides a Business Update
Bionano Genomics, Inc. (BNGO) Q2 2026 Earnings Call Transcript
Bionano Genomics Raises FY2026 Sales Guidance from $30.000M-$33.000M to $31.000M-$33.000M vs $32.137M Est
Bionano Genomics Sees Q3 Sales $8.200M-$8.600M vs $8.575M Est
Bionano to Report Second Quarter 2026 Financial Results and Host a Conference Call Webcast on August 10, 2026
Bionano Announces Hiring of Chief Scientific Officer
Bionano Announces 67% Year-Over-Year Growth in Studies Featuring Optical Genome Mapping at ESHG 2026, Reflecting Expanding Global Adoption
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.